Stock NVIV INVIVO THERAPEUTICS HOLDINGS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials InVivo Therapeutics Holdings Corp.

Equities

NVIV

US46186M6057

Advanced Medical Equipment & Technology

Market Closed - OTC Markets
Other stock markets
 03:33:29 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.37 USD +2.78% Intraday chart for InVivo Therapeutics Holdings Corp. +2.78% -49.32%
Apr. 16 North American Morning Briefing : Powell Comments, -2- DJ
Apr. 02 North American Morning Briefing : Stocks Seen -2- DJ

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 26.36 14.05 3.715 17.15 15.63 4.5
Enterprise Value (EV) 1 14.3 -2.508 -1.573 -1.324 -2.093 -10.9
P/E ratio - - -0.19 x -0.62 x -1.52 x -0.34 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -0.61 x 0.2 x 0.14 x 0.15 x 0.21 x 1.03 x
EV / FCF -1.18 x 0.34 x 0.26 x 0.22 x 0.43 x 1.45 x
FCF Yield -84.5% 298% 385% 445% 235% 69.1%
Price to Book - 0.87 x 0.67 x 1 x 0.86 x 0.36 x
Nbr of stocks (in thousands) 1.83 12.4 22 847 1,371 1,915
Reference price 2 14,438 1,133 168.7 20.25 11.40 2.350
Announcement Date 3/12/18 4/1/19 2/20/20 3/1/21 3/7/22 3/1/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales - - - - - -
EBITDA 1 -23.3 -12.68 -11.44 -9.051 -9.856 -10.59
EBIT 1 -23.7 -12.77 -11.5 -9.097 -9.9 -10.65
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -26.74 -23.42 -11.83 -9.074 -9.895 -10.49
Net income 1 -26.74 -23.42 -11.83 -9.074 -9.895 -10.49
Net margin - - - - - -
EPS - - -881.9 -32.86 -7.478 -6.827
Free Cash Flow 1 -12.09 -7.48 -6.06 -5.889 -4.92 -7.53
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/12/18 4/1/19 2/20/20 3/1/21 3/7/22 3/1/23
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 12.1 16.6 5.29 18.5 17.7 15.4
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -12.1 -7.48 -6.06 -5.89 -4.92 -7.53
ROE (net income / shareholders' equity) -137% -179% -109% -73.3% -53.1% -62%
ROA (Net income/ Total Assets) -60.7% -49.2% -51.9% -36.4% -28.3% -32.8%
Assets 1 44.09 47.59 22.8 24.92 34.93 31.99
Book Value Per Share - 1,298 253.0 20.30 13.20 6.480
Cash Flow per Share - 1,342 300.0 20.60 13.90 6.730
Capex 1 0.07 0.07 0.01 0.04 0.08 0.16
Capex / Sales - - - - - -
Announcement Date 3/12/18 4/1/19 2/20/20 3/1/21 3/7/22 3/1/23
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
INVIVO THERAPEUTICS HOLDINGS CORP. Stock InVivo Therapeutics Holdings Corp.
-49.32% 1.15M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
RESMED, INC. Stock ResMed, Inc.
+26.76% 32.03B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. NVIV Stock
  4. Financials InVivo Therapeutics Holdings Corp.